Pharmacokinetics and Pharmacodynamics — MCQs

When atrial fibrillation persists despite digoxin therapy, an inadequate digoxin dose is suspected. Plasma levels of digoxin for confirmation are typically drawn after a certain interval following the last dose. Considering pharmacokinetic principles, which factor is most crucial for determining this appropriate sampling time?

Q165Medium

Single dose aminoglycoside administration is more preferable than 8 hourly dosing because of which of the following?

Q166Medium

Which of the following is false regarding spare receptors?

Q167Easy

Which of the following is NOT a prodrug?

Q168Easy

Which of the following is a prodrug of cetirizine?

Q169Easy

Which of the following is a CYP-450 inducer?

Q170Easy

What does the plasma concentration versus time graph indicate?

Pharmacokinetics and Pharmacodynamics Indian Medical PG Practice Questions and MCQs

Question 161: Which of the following does NOT induce microsomal enzymes?

A. Cimetidine (Correct Answer)
B. Griseofulvin
C. Rifampicin
D. Phenobarbitone

Explanation: **Explanation:** The core concept tested here is the distinction between **Enzyme Inducers** and **Enzyme Inhibitors**. Microsomal enzymes (primarily the Cytochrome P450 system in the liver) are responsible for the metabolism of many drugs. **1. Why Cimetidine is the correct answer:** Cimetidine is a potent **Enzyme Inhibitor**. It binds to the heme iron of the CYP450 system, reducing the metabolic activity of the liver. This leads to decreased clearance and increased plasma concentrations of co-administered drugs (like Warfarin or Theophylline), potentially causing toxicity. **2. Why the other options are incorrect:** * **Phenobarbitone:** A classic, potent inducer of CYP450 enzymes. It increases the synthesis of microsomal enzymes, accelerating the metabolism of itself and other drugs. * **Rifampicin:** One of the most powerful known enzyme inducers. It significantly reduces the half-life of drugs like oral contraceptives, often leading to therapeutic failure. * **Griseofulvin:** An antifungal agent known to induce hepatic microsomal enzymes, particularly affecting the metabolism of Warfarin. **High-Yield Clinical Pearls for NEET-PG:** To remember these for the exam, use these popular mnemonics: * **Enzyme Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin/Phenobarbitone, **R**ifampicin, **S**moking, **C**arbamazepine. * **Enzyme Inhibitors (VITAMIN K):** **V**alproate, **I**soniazid, **T**erfenadine, **A**miodarone, **M**ethylphenidate, **I**traconazole, **N**ight (Grapefruit) juice, **K**etoconazole (**C**imetidine and **E**rythromycin are also critical inhibitors). **Note:** Cimetidine also has anti-androgenic side effects (gynecomastia), making it a frequent topic in NEET-PG pharmacology questions.

Question 162: Which of the following cephalosporins does not require dose modifications even in the presence of decreased GFR?

A. Cefipine
B. Cefoperazone (Correct Answer)
C. Cefotaxime
D. Cefuroxime

Explanation: ### Explanation **Correct Answer: B. Cefoperazone** **1. Why Cefoperazone is Correct:** The primary mechanism for the elimination of most cephalosporins is renal excretion via glomerular filtration and tubular secretion. However, **Cefoperazone** and **Ceftriaxone** are notable exceptions. These drugs are primarily excreted through the **biliary tract (feces)** rather than the kidneys. Because their clearance is not dependent on the Glomerular Filtration Rate (GFR), they do not require dose adjustment in patients with renal impairment or renal failure. **2. Why the Other Options are Incorrect:** * **A. Cefepime:** A 4th-generation cephalosporin primarily excreted unchanged by the kidneys. Dose reduction is mandatory in renal insufficiency to prevent neurotoxicity (e.g., encephalopathy, seizures). * **C. Cefotaxime:** A 3rd-generation cephalosporin excreted mainly via the renal route. It requires dose modification when GFR falls below 20 mL/min. * **D. Cefuroxime:** A 2nd-generation cephalosporin that is almost entirely excreted by the kidneys. Accumulation occurs in renal failure, necessitating dose adjustments. **3. High-Yield Clinical Pearls for NEET-PG:** * **The "Biliary Duo":** Remember **Ceftriaxone** and **Cefoperazone** as the two cephalosporins that are primarily eliminated in bile. * **Disulfiram-like Reaction:** Cefoperazone contains a **methylthiotetrazole (MTT) side chain**, which can cause a disulfiram-like reaction with alcohol and hypoprothrombinemia (bleeding risk due to Vitamin K antagonism). * **Pseudomonas Coverage:** Cefoperazone and Ceftazidime are 3rd-generation cephalosporins with specific activity against *Pseudomonas aeruginosa*. * **Rule of Thumb:** For almost all other beta-lactams (except Nafcillin/Oxacillin), "If the Kidneys fail, lower the scale (dose)."

Question 163: When the same dose of a drug is repeated at half-life intervals, after how many half-lives is the steady-state (plateau) plasma drug concentration reached?

A. 2-3 half-lives
B. 4-5 half-lives (Correct Answer)
C. 6-7 half-lives
D. 8-10 half-lives

Explanation: ### Explanation **Concept of Steady State Concentration ($C_{ss}$)** Steady state is reached when the rate of drug administration equals the rate of drug elimination. When a drug is administered at fixed intervals (usually equal to its half-life), the plasma concentration rises in a predictable, exponential fashion. **Why 4-5 half-lives is correct:** The accumulation of a drug follows first-order kinetics. After each half-life, the drug concentration reaches a specific percentage of the ultimate steady-state level: * 1 Half-life: 50% of $C_{ss}$ * 2 Half-lives: 75% of $C_{ss}$ * 3 Half-lives: 87.5% of $C_{ss}$ * **4 Half-lives: 93.75% of $C_{ss}$** * **5 Half-lives: 96.875% of $C_{ss}$** In clinical practice, reaching >90-95% of the plateau is considered achieving steady state. Therefore, **4 to 5 half-lives** is the standard duration required. **Analysis of Incorrect Options:** * **A (2-3 half-lives):** At this stage, the drug has only reached 75-87.5% of its plateau. The concentration is still rising significantly and has not stabilized. * **C & D (6-10 half-lives):** While the drug technically continues to approach 100% mathematically, the incremental increase after 5 half-lives is clinically negligible. **High-Yield Clinical Pearls for NEET-PG:** 1. **Elimination Rule:** Just as it takes 4-5 half-lives to reach steady state, it also takes approximately **4-5 half-lives for a drug to be completely eliminated** from the body after stopping the dose. 2. **Independence of Dose:** The time to reach steady state depends **only on the half-life**, not on the dose or the frequency of administration (though the *level* of the plateau depends on the dose). 3. **Loading Dose:** To achieve the steady-state concentration immediately without waiting for 4-5 half-lives, a **Loading Dose** is administered.

Question 164: When atrial fibrillation persists despite digoxin therapy, an inadequate digoxin dose is suspected. Plasma levels of digoxin for confirmation are typically drawn after a certain interval following the last dose. Considering pharmacokinetic principles, which factor is most crucial for determining this appropriate sampling time?

A. Rate of absorption
B. Rate of distribution (Correct Answer)
C. Rate of clearance
D. Rate of elimination

Explanation: **Explanation:** The correct answer is **Rate of distribution (Option B)**. This is a classic pharmacokinetic concept essential for drugs that follow a **two-compartment model**, such as digoxin. Digoxin has a prolonged distribution phase (6–8 hours). After administration, the drug initially remains in the central compartment (blood) before moving into the peripheral compartment (tissues like the myocardium). Since the pharmacological effect of digoxin occurs at the tissue level, plasma levels drawn during the distribution phase will be falsely elevated and will not correlate with the drug’s clinical effect or toxicity. Therefore, sampling must be delayed until the **distribution equilibrium** is reached to ensure the plasma concentration reflects the tissue concentration. **Why other options are incorrect:** * **Rate of absorption (A):** While absorption determines how fast a drug enters the blood, it does not dictate the equilibrium between blood and the target organ (heart). * **Rate of clearance (C) and Elimination (D):** These factors determine the **half-life** and the time required to reach **steady-state** (usually 4–5 half-lives). While they influence the maintenance dose, they do not determine the specific timing of a post-dose sample (trough level) as critically as the distribution phase does for digoxin. **High-Yield Clinical Pearls for NEET-PG:** * **Sampling Time:** For Digoxin, blood should be drawn at least **6 to 8 hours** after the last dose. * **Volume of Distribution ($V_d$):** Digoxin has a very high $V_d$ (~7 L/kg) because it binds extensively to skeletal muscle. * **Therapeutic Window:** Narrow (0.5–2.0 ng/mL). * **Toxicity Predisposition:** Hypokalemia, hypomagnesemia, and hypercalcemia increase the risk of digoxin toxicity.

Question 165: Single dose aminoglycoside administration is more preferable than 8 hourly dosing because of which of the following?

A. Minimum Inhibitory Concentration (MIC)
B. Increased perfusion of the renal cortex
C. Post-antibiotic effect (Correct Answer)
D. None of the above

Explanation: ### Explanation The correct answer is **C. Post-antibiotic effect**. Aminoglycosides (e.g., Gentamicin, Amikacin) exhibit two key pharmacodynamic properties that justify **Once-Daily Dosing (ODD)** over traditional 8-hourly dosing: 1. **Concentration-Dependent Killing:** The higher the peak concentration ($C_{max}$) relative to the Minimum Inhibitory Concentration (MIC), the faster and more extensive the bacterial killing. 2. **Post-Antibiotic Effect (PAE):** This refers to the persistent suppression of bacterial growth even after the serum drug concentration falls below the MIC. Aminoglycosides have a prolonged PAE (often several hours). By giving a single large dose, we achieve a high $C_{max}$ and leverage a long PAE, ensuring efficacy even when drug levels are low. **Why other options are incorrect:** * **A. Minimum Inhibitory Concentration (MIC):** While the MIC is a benchmark for efficacy, it does not explain the *preference* for single dosing. In fact, in ODD, the drug level falls below the MIC for a significant part of the day; it is the PAE that maintains the effect during this "trough" period. * **B. Increased perfusion of the renal cortex:** This is factually incorrect. Aminoglycoside toxicity (nephrotoxicity) is related to the **accumulation** of the drug in the renal cortex. Single daily dosing actually *reduces* toxicity because the uptake mechanism in the renal tubules is saturable. A single high peak saturates the receptors, while frequent dosing leads to more continuous uptake and higher accumulation. **High-Yield Clinical Pearls for NEET-PG:** * **Toxicity:** Aminoglycosides are notorious for **Nephrotoxicity** (reversible ATN) and **Ototoxicity** (irreversible). * **Resistance:** The most common mechanism of resistance is the production of **bacterial inactivating enzymes** (e.g., transferases). * **Synergy:** They are often combined with Cell Wall Inhibitors (Penicillins/Vancomycin) to enhance entry into the bacterial cell, especially in Enterococcal endocarditis.

Question 166: Which of the following is false regarding spare receptors?

A. They are needed for binding a drug to achieve the maximum effect. (Correct Answer)
B. They respond to agonists only.
C. They do not alter maximal efficacy.
D. They can be detected by finding that EC50 < Kd for the agonist.

Explanation: ### Explanation **Concept of Spare Receptors** Spare receptors exist when the maximal biological response of a drug is achieved by occupying only a small fraction of the total receptor population. This phenomenon occurs due to **signal amplification** (e.g., one receptor activating multiple G-proteins). **1. Why Option A is the Correct Answer (False Statement):** In a system with spare receptors, the maximum effect ($E_{max}$) is reached **before** all receptors are occupied. Therefore, you do **not** need to bind the drug to all receptors (including spare ones) to achieve the maximum effect. Spare receptors are "extra" and remain unoccupied even when the drug is exerting its full physiological potential. **2. Analysis of Other Options:** * **Option B (True):** Spare receptors are functional receptors that respond to agonists. They are "spare" only in the context of the specific tissue response, not because they are structurally different or inactive. * **Option C (True):** The presence of spare receptors does not change the maximal efficacy ($E_{max}$) of a drug; it primarily affects **sensitivity**. It allows a tissue to reach $E_{max}$ at much lower concentrations of an agonist. * **Option D (True):** This is the classic mathematical definition of spare receptors. * **$K_d$:** Concentration needed to bind 50% of receptors. * **$EC_{50}$:** Concentration needed to produce 50% of the maximal effect. * If $EC_{50} < K_d$, it proves that half the maximal effect was achieved by binding less than half the receptors, confirming the presence of spare receptors. **High-Yield Clinical Pearls for NEET-PG:** * **Irreversible Antagonists:** In the presence of spare receptors, low doses of an irreversible antagonist may shift the log-dose response curve to the right (increasing $EC_{50}$) without decreasing $E_{max}$. $E_{max}$ only decreases once the "spare" capacity is exhausted. * **Example:** The heart has a large reserve of $\beta_1$ adrenoceptors; maximum inotropic effect is achieved even when many receptors are unoccupied. * **Key Formula:** If $EC_{50} = K_d$, there are **no** spare receptors. If $EC_{50} < K_d$, spare receptors are present.

Question 167: Which of the following is NOT a prodrug?

A. Lisinopril (Correct Answer)
B. Enalapril
C. Levodopa
D. Sulindac

Explanation: The correct answer is **Lisinopril**. A **prodrug** is a pharmacologically inactive compound that must undergo metabolic conversion (usually in the liver) to become an active drug [2], [4]. **1. Why Lisinopril is the correct answer:** Most ACE inhibitors are prodrugs (esters) designed to improve oral bioavailability [4]. However, **Lisinopril** and **Captopril** are the two primary exceptions; they are already in their active form and do not require hepatic activation [1], [3]. This makes them preferred in patients with hepatic impairment. **2. Analysis of Incorrect Options:** * **Enalapril:** It is a classic prodrug converted by hepatic esterases into its active metabolite, **Enalaprilat** [4]. (Note: Enalaprilat is available only intravenously because it has poor oral absorption). * **Levodopa:** It is the metabolic precursor to **Dopamine**. Levodopa can cross the blood-brain barrier, whereas dopamine cannot. It is converted to active dopamine by the enzyme DOPA decarboxylase. * **Sulindac:** An NSAID of the indene derivative class. It is an inactive sulfoxide that must be reduced to an active **sulfide** metabolite in the body. **High-Yield Clinical Pearls for NEET-PG:** * **ACE Inhibitor Mnemonic:** All ACE inhibitors are prodrugs **EXCEPT** Lisinopril and Captopril [1]. * **Active Metabolites:** Always remember that **Enalaprilat** is the active form of Enalapril [4], and **Foscarnet** is an example of an antiviral that is NOT a prodrug (unlike Acyclovir). * **Advantage of Prodrugs:** They are often designed to increase absorption (e.g., Valacyclovir), decrease gastrointestinal toxicity (e.g., Sulindac), or ensure site-specific delivery (e.g., Levodopa) [2], [4].

Question 168: Which of the following is a prodrug of cetirizine?

A. Foxefenadone
B. Terfenadine
C. Hydroxyzine (Correct Answer)
D. Azelastine

Explanation: **Explanation:** The correct answer is **Hydroxyzine**. **Why Hydroxyzine is correct:** Hydroxyzine is a first-generation H1-receptor antagonist. It undergoes extensive hepatic metabolism via the enzyme alcohol dehydrogenase to form its active carboxylic acid metabolite, **Cetirizine**. Since Cetirizine is the active form derived from the metabolic conversion of Hydroxyzine, Hydroxyzine acts as the prodrug. Cetirizine itself is a second-generation antihistamine known for being less sedative because it is a zwitterion and does not readily cross the blood-brain barrier. **Analysis of Incorrect Options:** * **Terfenadine:** This was the first non-sedating antihistamine. It is actually the prodrug of **Fexofenadine**. Terfenadine was withdrawn from the market because it caused QTc prolongation and *Torsades de Pointes* when its metabolism was inhibited (e.g., by erythromycin or ketoconazole). * **Fexofenadine:** This is the active metabolite of Terfenadine. It is a third-generation antihistamine and is not a prodrug. * **Azelastine:** This is a second-generation antihistamine primarily used as a nasal spray for allergic rhinitis or ophthalmic drops for conjunctivitis. It is an active drug, not a prodrug. **High-Yield Clinical Pearls for NEET-PG:** * **Metabolite Pairs:** Remember **Terfenadine → Fexofenadine**, **Loratadine → Desloratadine**, and **Hydroxyzine → Cetirizine**. * **Safety Profile:** Cetirizine is unique among second-generation antihistamines as it may cause mild sedation in some patients compared to Fexofenadine (the "most" non-sedating). * **Pharmacokinetics:** Most second-generation antihistamines have long half-lives, allowing for once-daily dosing.

Question 169: Which of the following is a CYP-450 inducer?

A. Cimetidine
B. Ketoconazole
C. Phenobarbitone (Correct Answer)
D. All of the above

Explanation: **Explanation:** The Cytochrome P450 (CYP450) enzyme system is the primary pathway for drug metabolism in the liver. Drugs that interact with this system are classified as either **inducers** or **inhibitors**. **Why Phenobarbitone is Correct:** Phenobarbitone is a classic **CYP450 inducer**. It works by increasing the synthesis of microsomal enzymes (via activation of nuclear receptors like CAR). This leads to an increased rate of metabolism for co-administered drugs (e.g., Warfarin, Oral Contraceptive Pills), resulting in **decreased plasma concentrations** and potential therapeutic failure. **Why Other Options are Incorrect:** * **Cimetidine:** This is a potent **CYP450 inhibitor**. It binds to the heme iron of the CYP450 enzyme, reducing the metabolism of other drugs (e.g., Theophylline, Phenytoin), which can lead to toxicity. * **Ketoconazole:** This is a well-known antifungal that acts as a strong **CYP450 inhibitor** (specifically CYP3A4). It is often used in pharmacology questions to illustrate drug-drug interactions that increase the risk of arrhythmias (e.g., when taken with Terfenadine). **High-Yield Clinical Pearls for NEET-PG:** To remember these for the exam, use these popular mnemonics: 1. **Enzyme Inducers (GPRS Cell Phone):** **G**riseofulvin, **P**henytoin, **R**ifampicin, **S**moking, **C**arbamazepine, **P**henobarbitone. 2. **Enzyme Inhibitors (VITAMIN K):** **V**alproate, **I**soniazid, **T**amoxifen, **A**miodarone, **M**acrolides (except Azithromycin), **I**ndinavir, **N**etupitant, **K**etoconazole (and Cimetidine/Grapefruit juice). *Note:* Enzyme **induction** usually takes 1–2 weeks to manifest (requires protein synthesis), whereas enzyme **inhibition** occurs almost immediately.

Question 170: What does the plasma concentration versus time graph indicate?

A. Half-life
B. Clearance
C. Elimination
D. Bioavailability (Correct Answer)

Explanation: ***Bioavailability*** - The **plasma concentration versus time graph** is primarily used to calculate bioavailability by comparing the **area under the curve (AUC)** between different routes of administration (oral vs IV). - **Bioavailability (F)** is determined using the formula: F = AUC_oral / AUC_IV × Dose_IV / Dose_oral, making this graph essential for **bioequivalence studies**. *Half-life* - **Half-life** is derived from the **elimination phase slope** of the plasma concentration curve, not the overall graph comparison. - It represents the time required for plasma concentration to decrease by **50%** and is calculated from a single curve's declining phase. *Clearance* - **Clearance** is calculated using the formula **Dose/AUC** and represents the volume of plasma cleared per unit time. - While the graph provides AUC data needed for clearance calculation, the graph itself doesn't directly indicate clearance. *Elimination* - **Elimination rate constant** is determined from the **slope of the terminal elimination phase** of a single concentration-time curve. - The graph comparison between routes doesn't directly measure elimination kinetics but rather **absorption and bioavailability differences**.

Practice by Chapter

Absorption and Bioavailability

Practice Questions

Drug Distribution and Protein Binding

Practice Questions

Biotransformation and Metabolism Pathways

Practice Questions

Renal and Non-renal Excretion

Practice Questions

Compartment Models

Practice Questions

Dose-Response Relationships

Practice Questions

Drug Efficacy and Potency

Practice Questions

Drug Tolerance and Tachyphylaxis

Practice Questions

Population Pharmacokinetics

Practice Questions

Pharmacokinetic Variability

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free